A61M 2202/0421
Beta-2-microglobulin
A61M2202/0421 (Beta-2-microglobulin) appears on 12 US grants and 8 published applications in this corpus.
Search patents in A61M- Granted patents
- 12
- Published applications
- 8
- Assignees
- 14
- Inventors
- 34
- Latest grant
- 8 Jan 2013
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 3 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood8 Jan 2013US 8,349,550 B2CytoSorbents Corporation
- Methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood7 Dec 2010US 7,846,650 B2CytoSorbents Corporation
- Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood, generated as a result of extracorporeal blood processing25 Dec 2007US 7,312,023 B2RenalTech International, LLC
- Use of an adsorbent gel for eliminating and purifying biomolecules8 Jun 2004US 6,746,607 B1Centre National De La Recherche Scientifique
- Method of removing beta-2 microglobulin from blood9 Jul 2002US 6,416,487 B1Renal Tech International LLC
- Hollow fibers for outside-in-dialysis applications9 Dec 2021US 2021/0381131 A1Novaflux Inc.
- Methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood28 Apr 2011US 2011/0097700 A1Cytosorbents, Inc., Stefan Brodie, Donald Brodie
- Methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood12 Jun 2008US 2008/0138434 A1Medasorb Corporation
- Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood, generated as a result of extracorporeal blood processing8 Nov 2007US 2007/0258983 A1Renal Tech International LLC
- Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in physiologic fluids24 Mar 2005US 2005/0061742 A1Renal Tech International LLC
Most cited
By later US patents
- Method of measuring the effect of a dialysis treatment54US 5,788,846 AGambro AB · 1998
- Method of removing beta-2 microglobulin from blood46US 6,416,487 B1Renal Tech International LLC · 2002
- Method of removing beta-2 microglobulin from blood42US 5,904,663 A1999
- Absorbent of .beta..sub.2 -microglobulin35US 5,051,185 AAsahi Kasei Kogyo Kabushiki Kaisha · 1991
- Apparatus for treating whole blood comprising concentric cylinders defining an annulus therebetween34US 6,099,730 AMassachusetts Institute of Technology · 2000